Ian W. Folkert
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ian W. Folkert has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Robert E. Roses
Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania
2 shared publications - Alexander Joseph Lazar
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
1 shared publication - Ashley M. Fuller
Perelman School of Medicine, University of Pennsylvania 5 Department of Pathology and Laboratory Medicine Philadelphia, PA
1 shared publication Benjamin M. Jackson
Division of Vascular Surgery and Endovascular Therapy, Hospital of the University of Pennsylvania, Philadelphia, PA
1 shared publicationC. A. Sims
Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
1 shared publicationC. W. Schwab
Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
1 shared publication
Latest Publications
- Open Access
- 30 September 2024
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 221 (10)
An iron-rich subset of macrophages promotes tumor growth through a Bach1-Ednrb axis
We define a subset of macrophages in the tumor microenvironment characterized by high intracellular iron and enrichment of heme and iron metabolism genes. These iron-rich tumor-associated macrophages (iTAMs) supported angiogenesis and immunosuppression in the tumor microenvironment and were conserved between mice and humans. iTAMs comprise two additional subsets based on gene expression profile and location—perivascular (pviTAM) and stromal (stiTAM). We identified the endothelin receptor type B (Ednrb) as a specific marker of iTAMs and found myeloid-specific deletion of Ednrb to reduce tumor growth and vascular density. Further studies identified the transcription factor Bach1 as a repressor of the iTAM transcriptional program, including Ednrb expression. Heme is a known inhibitor of Bach1, and, correspondingly, heme exposure induced Ednrb and iTAM signature genes in macrophages. Thus, iTAMs are a distinct macrophage subset regulated by the transcription factor Bach1 and characterized by Ednrb-mediated immunosuppressive and angiogenic functions.
- 30 September 2024
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 221 (10)
Open AccessAn iron-rich subset of macrophages promotes tumor growth through a Bach1-Ednrb axis
We define a subset of macrophages in the tumor microenvironment characterized by high intracellular iron and enrichment of heme and iron metabolism genes. These iron-rich tumor-associated macrophages (iTAMs) supported angiogenesis and immunosuppression in the tumor microenvironment and were conserved between mice and humans. iTAMs comprise two additional subsets based on gene expression profile and location—perivascular (pviTAM) and stromal (stiTAM). We identified the endothelin receptor type B (Ednrb) as a specific marker of iTAMs and found myeloid-specific deletion of Ednrb to reduce tumor growth and vascular density. Further studies identified the transcription factor Bach1 as a repressor of the iTAM transcriptional program, including Ednrb expression. Heme is a known inhibitor of Bach1, and, correspondingly, heme exposure induced Ednrb and iTAM signature genes in macrophages. Thus, iTAMs are a distinct macrophage subset regulated by the transcription factor Bach1 and characterized by Ednrb-mediated immunosuppressive and angiogenic functions.
- 1 May 2018
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 67 (5) , 1530-1536.e2
Impact of acute postoperative limb ischemia after cardiac and thoracic aortic surgery
- 1 May 2018
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 67 (5) , 1530-1536.e2
Impact of acute postoperative limb ischemia after cardiac and thoracic aortic surgery
- 8 July 2016
- Published by Wiley in Journal of Surgical Oncology
- Vol. 114 (3) , 311-315
Value in palliative cancer surgery: A critical assessment
Emergency operations are associated with increased morbidity, mortality, and cost compared to elective operations. Palliative and emergent surgery for patients with advanced malignancies is associated with additional risk and remains controversial. Emergent or palliative interventions can be broadly categorized according to indication. Tumor related complications (bleeding, obstruction, or perforation) merit specific consideration, as do specific presentations such as pneumoperitoneum, pneumatosis intestinalis, or peritonitis from other causes that may arise during active therapy for malignancies. Although nonoperative, endoscopic, and interventional treatment modalities are frequently available, surgery remains the only effective therapy in selected situations such as small intestinal obstruction and tumor perforation. Selection of patients for surgery requires consideration of factors including overall prognosis, performance status, and patients’ priorities. Selection and risk assessment tools underscore the limited capacity of patients’ with higher risk features for durable recovery but do not supplant nuanced clinical judgment. J. Surg. Oncol. 2016;114:311–315.
- 8 July 2016
- Published by Wiley in Journal of Surgical Oncology
- Vol. 114 (3) , 311-315
Value in palliative cancer surgery: A critical assessment
Emergency operations are associated with increased morbidity, mortality, and cost compared to elective operations. Palliative and emergent surgery for patients with advanced malignancies is associated with additional risk and remains controversial. Emergent or palliative interventions can be broadly categorized according to indication. Tumor related complications (bleeding, obstruction, or perforation) merit specific consideration, as do specific presentations such as pneumoperitoneum, pneumatosis intestinalis, or peritonitis from other causes that may arise during active therapy for malignancies. Although nonoperative, endoscopic, and interventional treatment modalities are frequently available, surgery remains the only effective therapy in selected situations such as small intestinal obstruction and tumor perforation. Selection of patients for surgery requires consideration of factors including overall prognosis, performance status, and patients’ priorities. Selection and risk assessment tools underscore the limited capacity of patients’ with higher risk features for durable recovery but do not supplant nuanced clinical judgment. J. Surg. Oncol. 2016;114:311–315.
- Open Access
- 1 January 2016
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 22 (11) , 3105-3116
Multidisciplinary management of nonfunctional neuroendocrine tumor of the pancreas
Pancreatic neuroendocrine tumors (PNETs) are a rare and diverse group of tumors; nonfunctional (NF) PNETs account for the majority of cases. Most patients with NF-PNETs have metastatic disease at the time of presentation. A variety of treatment modalities exist, including medical, liver directed, and surgical treatments. Aggressive surgical management is associated with prolonged survival, however available data are limited by selection bias and the frequent combination of PNETs with carcinoid tumors. Although few patients with metastatic disease will be cured, application of currently available therapies in a multidisciplinary setting can lead to excellent outcomes with prolonged patient survival.
- 1 January 2016
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 22 (11) , 3105-3116
Open AccessMultidisciplinary management of nonfunctional neuroendocrine tumor of the pancreas
Pancreatic neuroendocrine tumors (PNETs) are a rare and diverse group of tumors; nonfunctional (NF) PNETs account for the majority of cases. Most patients with NF-PNETs have metastatic disease at the time of presentation. A variety of treatment modalities exist, including medical, liver directed, and surgical treatments. Aggressive surgical management is associated with prolonged survival, however available data are limited by selection bias and the frequent combination of PNETs with carcinoid tumors. Although few patients with metastatic disease will be cured, application of currently available therapies in a multidisciplinary setting can lead to excellent outcomes with prolonged patient survival.
- 26 August 2014
- Published by Springer Nature in European Journal of Trauma and Emergency Surgery
- Vol. 41 (2) , 203-209
Initial venous lactate levels in patients with isolated penetrating extremity trauma: a retrospective cohort study
Elevated initial lactate levels have been shown to be associated with severe injury in trauma patients, but some patients who do not appear to be in shock also presented with elevated lactate levels. We hypothesized that in hemodynamically stable patients with isolated penetrating extremity trauma, initial lactate level does not predict clinically significant bleeding.
- 26 August 2014
- Published by Springer Nature in European Journal of Trauma and Emergency Surgery
- Vol. 41 (2) , 203-209
Initial venous lactate levels in patients with isolated penetrating extremity trauma: a retrospective cohort study
Elevated initial lactate levels have been shown to be associated with severe injury in trauma patients, but some patients who do not appear to be in shock also presented with elevated lactate levels. We hypothesized that in hemodynamically stable patients with isolated penetrating extremity trauma, initial lactate level does not predict clinically significant bleeding.